Results 11 to 20 of about 5,368 (169)

Molecular genetics of follicular cell thyroid carcinoma

open access: yesКлиническая и экспериментальная тиреоидология, 2016
Thyroid cancer is the most frequent endocrine malignancy. In the most cases thyroid cancer arises from follicular cells. Diagnosis of the cancer is based on the cytological analysis of fine needle aspiration biopsy of thyroid nodes.
Valentina D. Yakushina   +5 more
doaj   +1 more source

Phenotype-Genotype Correlation in Colorectal Cancer: A Real-Life Study

open access: yesGE: Portuguese Journal of Gastroenterology, 2021
Background and Aims: Colorectal cancer (CRC) is a heterogeneous disease with distinctive genetic pathways, such as chromosomal instability, microsatellite instability and methylator pathway.
Catarina Frias-Gomes   +14 more
doaj   +1 more source

BRAF mutation in colorectal cancer: An update [PDF]

open access: yesArchive of Oncology, 2023
Colon cancer is a leading cause of cancer-related deaths worldwide. About 10% of all colon cancer patients are found to have a mutation in BRAF proto-oncogene that arise as a result of a substitution of amino acid valine with glutamate at position 600 ...
Colombo Alfredo   +2 more
doaj  

Dabrafenib: A narrative drug review

open access: yesCancer Research, Statistics, and Treatment, 2020
Activating mutations in the BRAF gene lead to an unregulated downstream signaling of the MAPK/extracellular-signal-regulated kinase pathway. This pathway is implicated in a range of solid tumors, and BRAF inhibitors are an attractive option in the ...
Lakhan Kashyap   +2 more
doaj   +1 more source

Clinicopathological Significance of BRAF (V600E), NRAS (Q61K) and TERT (C228T, C250T and SNP Rs2853669) Mutations in Bulgarian Papillary Thyroid Carcinoma Patients

open access: yesActa Medica Bulgarica, 2021
Introduction: Thyroid carcinoma is the most common endocrine cancer. Some somatic mutations in genes (BRAF, NRAS and TERT) involved in key signaling pathways and genome stability have been recently identified to play an important role in its development.
Vidinov K.   +8 more
doaj   +1 more source

Melanoma: clinical-pathological and molecular analysis in patients of Ibague city, Colombia

open access: yesDuazary, 2020
This study aimed to establish the clinicopathological characteristics of patients with melanoma and its association with BRAF gene mutations. The pathology reports and paraffin-embedded tumor samples from 47 women and 30 men with melanoma, with an ...
Carlos Puentes   +5 more
doaj   +1 more source

BRAF, NRAS, KIT, TERT, GNAQ/GNA11 Mutation Profile and Histomorphological Analysis of Anorectal Melanomas: A Clinicopathologic Study

open access: yesTürk Patoloji Dergisi, 2023
Objective: Primary anorectal melanomas (AMs) are uncommon neoplasms with aggressive behavior. Molecular profile and clinicopathologic features of AMs are still not well established.
Orhun Cig TASKIN   +6 more
doaj   +1 more source

전이성 대장암의 새로운 표적치료

open access: yesThe Ewha Medical Journal, 2021
Over the past decade, substantial advances have been made in the individualization of therapeutic strategies for metastatic colorectal cancer (mCRC).

doaj   +1 more source

Molecular testing approaches in thyroid cancer diagnosis

open access: yesJournal of Biochemical and Clinical Genetics, 2020
Thyroid cancer (TC) is the most common endocrine malignancy worldwide, with an annual incidence of around 300,000 cases. In recent decades, the incidence of TC in many countries, including Saudi Arabia, has increased significantly.
Abdul-Mohsen Gaeth AlHejaily   +1 more
doaj   +1 more source

Super-enhancer receives signals from the extracellular matrix to induce PD-L1-mediated immune evasion via integrin/BRAF/TAK1/ERK/ETV4 signaling

open access: yesCancer Biology & Medicine, 2022
Objective: PD-L1 and PD-L2 expression levels determine immune evasion and the therapeutic efficacy of immune checkpoint blockade. The factors that drive inducible PD-L1 expression have been extensively studied, but mechanisms that result in constitutive ...
Panpan Ma   +12 more
doaj   +1 more source

Home - About - Disclaimer - Privacy